Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Clinical trial NCT04308330 · RECRUITING

Trial details

NCT number: NCT04308330
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ewing Sarcoma Rhabdomyosarcoma Wilms Tumor Neuroblastoma Hepatoblastoma Germ Cell Tumor

Start date: 2017-03-17
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.